A team of researchers in Madrid, Spain, and another team in Toronto, Canada, are the first in the world to use focused ultrasound technology to target a new area of the brain in patients with Parkinson’s disease and potentially curb, or even reverse, its progression.
We welcome Claude Wasserstein, founder and CEO of Fine Day Ventures, to our dedicated group of goodwill ambassadors who provide advice and assist with fundraising and awareness efforts.
The COVID-19 pandemic has had a dramatic impact on all our lives— our homes, our families, our businesses, and our health have all been affected. The focused ultrasound community is no exception.
Foundation team members and an anonymous donor joined forces to improve the daily life of residents and staff at the Cedars Healthcare Center amid the pandemic.
Omar Ishrak, Executive Chairman and Chairman of the Board at Medtronic, and Chairman of the Board at Intel, will discuss, “The Role of MedTech in Driving Patient Outcomes.”
The Foundation’s Young Investigator Awards encourage quality research by those early in their career. This year, we recognize the work of nine individuals from four countries.
The focused ultrasound research community is actively pursuing the treatment of various stages of breast cancer in nine ongoing clinical trials worldwide.
After undergoing focused ultrasound therapy at Brigham and Women’s Hospital, one patient is enjoying the ability to paint, work as an accountant, and do crossword puzzles again.
The community mourns the loss of Nettie Williams-Parker, the nursing lead for the West Virginia University Medicine’s focused ultrasound program, due to complications of COVID-19. She is pictured here with a patient.
Researchers in Switzerland have developed a novel neuromodulation sequence for aggregating and uncaging drug carriers at a circuit-specific location in the brain.
Dr. Jin Woo Chang’s group reports additional outcome data on their groundbreaking clinical trial to open the blood-brain barrier prior to chemotherapy administration in patients with glioblastoma.
A team from Sunnybrook Research Institute and Sunnybrook Health Sciences Center provides an overview of the growth in the field of focused ultrasound brain applications over the last five years.
A grant from the Defense Advanced Research Projects Agency will help develop implantable focused ultrasound neuromodulation devices to treat patients with traumatic spinal cord injury.
A collaborative research team led by Allison Payne, PhD, and Pejman Ghanouni, MD, PhD, has completed a project to combat a potential side effect of focused ultrasound treatment – skin burns.
Theraclion has obtained the CE Mark for the second generation of Sonovein®, its focused ultrasound treatment solution for varicose veins, allowing for an accelerated commercial roll-out.
